Seroquel user wants FDA to see sealed papers

A patient who claims the psychiatric drug Seroquel gave him diabetes has asked a judge to unseal AstraZeneca's confidential documents about its side effects--before the FDA decides whether to grant a new indication covering millions of patients with depression and/or anxiety. Report

Suggested Articles

Despite having lost some of its novelty, AZ's Brilinta is touting bleeding data over aspirin that could be a big break in acute coronary syndrome.

More than a year after J&J and Bayer pulled the plug on Xarelto in patients after a rare valve replacement, the pair are still seeking answers.

Having already whiffed on one crucial heart failure trial, Novartis is focusing on "profound" data from its Entresto studies in hopes for another go.